临床血细胞相关基因用于辅助结肠癌治疗
Qi Zhang1,2, Xiao Feng1, Mingming Zhang1,3
1Department of General Surgery, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China.
BMC genomics
|August 1, 2023
概括
血细胞 (PC) 透会影响结肠癌 (CC) 的预后和免疫治疗. 这项研究确定了关键基因和与瘤免疫微环境 (TIME) 和治疗敏感性相关的风险评分.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 瘤免疫微环境 (TIME) 在结肠癌 (CC) 中至关重要.
- 血细胞 (PC) 在抗瘤免疫力中起着重要作用.
- 在CC预后和免疫治疗中缺乏PC透的全面分析.
研究的目的:
- 系统地分析CC中的PC透情况.
- 建立一个预后基因表达模型.
- 评估CC中PC透的免疫治疗和临床意义.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库用于CC患者数据.
- 采用权重基因协同表达网络分析 (WGCNA) 来识别PC相关基因.
- 应用基因本体学 (GO),KEGG,GSVA,ESTIMATE和prrophetic算法用于途径和灵敏度分析.
主要成果:
- 确定了313个PC相关基因和5个关键预后基因.
- 开发了一个与瘤突变负担 (TMB) 和时间显著相关的风险得分.
- 在风险群体中表现出不同的途径活动和化疗敏感性.
- 发现了CD177基因在CC中的生物学作用.
结论:
- PC 透是CC预后和免疫反应的一个关键因素.
- 开发的风险评分可以预测临床结果和免疫治疗反应.
- 确定CD177作为CC进展和免疫调节中的关键基因.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.8K
06:19Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer
Published on: July 18, 2017
10.1K
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
